Phenomics Health Advances Precision Medicine with Products that Integrate Medication Selection, Adherence, Dose Tailoring and Monitoring
Plymouth, MI – May 23, 2022 – Phenomics Health Inc., a bioinformatics-based precision medicine company, today announced the commercial integration of six PrecīsMed® pharmacometabolomic (PMx) and PredictScript™ pharmacogenomic (PGx) clinical…
Phenomics Health Validates Patented Technology Following Seed Financing
Phenomics Health Inc., a platform bioinformatics-based precision medicine company, today announced completion of clinical product development and validation for its pharmacometabolomics (PMx) PrecīsMed® technology in its new CLIA laboratory located in Michigan Life Science and Innovation Center. The company’s laboratory operations, validation, as well as ongoing research and product development, have been funded with seed financing through experienced healthcare investors.
Phenomics Health Inc. Acquires Patented Pharmacometabolomic Technology
First Integrated Pharmacogenomics and Metabolomics Platform Offers Potential to Improve Patient Outcomes, Lower Costs in Medication Therapy
Phenomics Health Inc. Co-Founder Presents at the Annual Precision Medicine World Conference
Dr. Brian D. Athey, co-founder and Chief Science & Technology Officer of Phenomics Health Inc. (PHI), presented the PHI vision and current activities at the 11th Annual Precision Medicine World Conference (PMWC) in Silicon Valley